BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 25468144)

  • 21. In-vivo brain neuroimaging provides a gateway for integrating biological and clinical biomarkers of Alzheimer's disease.
    Cui J; Zufferey V; Kherif F
    Curr Opin Neurol; 2015 Aug; 28(4):351-7. PubMed ID: 26132531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integration of (18)FDG-PET Metabolic and Functional Connectomes in the Early Diagnosis and Prognosis of the Alzheimer's Disease.
    Zippo AG; Castiglioni I
    Curr Alzheimer Res; 2016; 13(5):487-97. PubMed ID: 26567731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Magnetic resonance imaging of Alzheimer's disease.
    Lehéricy S; Marjanska M; Mesrob L; Sarazin M; Kinkingnehun S
    Eur Radiol; 2007 Feb; 17(2):347-62. PubMed ID: 16865367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. La lunga attesa: towards a molecular approach to neuroimaging and therapeutics in Alzheimer's disease.
    Villemagne VL; Ng S; Cappai R; Barnham KJ; Fodero-Tavoletti MT; Rowe CC; Masters CL
    Neuroradiol J; 2006 Oct; 19(4):453-74. PubMed ID: 24351248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain imaging in the study of Alzheimer's disease.
    Reiman EM; Jagust WJ
    Neuroimage; 2012 Jun; 61(2):505-16. PubMed ID: 22173295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation of phosphorus-31 magnetic resonance spectroscopy and morphologic findings in Alzheimer's disease.
    Pettegrew JW; Panchalingam K; Moossy J; Martinez J; Rao G; Boller F
    Arch Neurol; 1988 Oct; 45(10):1093-6. PubMed ID: 3178529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood-based biomarkers of Alzheimer's disease: diagnostic algorithms and new technologies.
    Carmona P; Molina M; Toledano A
    Curr Alzheimer Res; 2016; 13(4):450-64. PubMed ID: 26567739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Magnetic-resonance imaging to assess Alzheimer's disease.
    Skoog I
    Lancet; 2002 May; 359(9317):1538-9. PubMed ID: 12047960
    [No Abstract]   [Full Text] [Related]  

  • 29. Healthy and Pathological Brain Aging: From the Perspective of Oscillations, Functional Connectivity, and Signal Complexity.
    Ishii R; Canuet L; Aoki Y; Hata M; Iwase M; Ikeda S; Nishida K; Ikeda M
    Neuropsychobiology; 2017; 75(4):151-161. PubMed ID: 29466802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymphocytes, Platelets, Erythrocytes, and Exosomes as Possible Biomarkers for Alzheimer's Disease Clinical Diagnosis.
    Pluta R; Ułamek-Kozioł M
    Adv Exp Med Biol; 2019; 1118():71-82. PubMed ID: 30747418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biological markers and diagnostic investigations in Alzheimer's disease.
    Wahlund LO
    Acta Neurol Scand Suppl; 1996; 165():85-91. PubMed ID: 8740993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antemortem laboratory diagnosis of Alzheimer's disease.
    Gauthier S; Robitaille Y; Quirion R; Leblanc R
    Prog Neuropsychopharmacol Biol Psychiatry; 1986; 10(3-5):391-403. PubMed ID: 3541044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospects for prediction: ethics analysis of neuroimaging in Alzheimer's disease.
    Illes J; Rosen A; Greicius M; Racine E
    Ann N Y Acad Sci; 2007 Feb; 1097():278-95. PubMed ID: 17413029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain glucose metabolism during hypoglycemia in type 1 diabetes: insights from functional and metabolic neuroimaging studies.
    Rooijackers HM; Wiegers EC; Tack CJ; van der Graaf M; de Galan BE
    Cell Mol Life Sci; 2016 Feb; 73(4):705-22. PubMed ID: 26521082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systematic review of
    Jett S; Boneu C; Zarate C; Carlton C; Kodancha V; Nerattini M; Battista M; Pahlajani S; Williams S; Dyke JP; Mosconi L
    Front Aging Neurosci; 2023; 15():1183228. PubMed ID: 37273652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insight into the Molecular Imaging of Alzheimer's Disease.
    Arora A; Bhagat N
    Int J Biomed Imaging; 2016; 2016():7462014. PubMed ID: 26880871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Problems associated with biological markers of Alzheimer's disease.
    Frey HJ; Mattila KM; Korolainen MA; Pirttilä T
    Neurochem Res; 2005 Dec; 30(12):1501-10. PubMed ID: 16362769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Legal Implications of Detecting Alzheimer's Disease Earlier.
    Preston J; McTeigue J; Opperman C; Scott Krieg JD; Brandt-Fontaine M; Yasis A; Shen FX
    AMA J Ethics; 2016 Dec; 18(12):1207-1217. PubMed ID: 28009247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuro-imaging in the diagnosis of Alzheimer's disease. I. Computer tomography and magnetic resonance imaging.
    Scheltens P; Weinstein HC; Leys D
    Clin Neurol Neurosurg; 1992; 94(4):277-89. PubMed ID: 1335854
    [No Abstract]   [Full Text] [Related]  

  • 40. Neuroimaging Biomarkers for Psychosis.
    Hager BM; Keshavan MS
    Curr Behav Neurosci Rep; 2015 Mar; 2015():1-10. PubMed ID: 25883891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.